Effects of Cognitive-motor Training on Cognition, Depression and Daily Functioning in Patients With Mild Cognitive Impairment (MCI)
Conditions: Mild Cognitive Impairment Interventions: Device: cognitive training via immersive virtual reality; Other: cognitive training via paper and pencil; Other: motor stimulation Sponsors: Universidad de Zaragoza Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Postpartum Video Education in High Risk Populations
Conditions: Postpartum Hemorrhage; Postpartum Depression; Postpartum Sepsis; Postpartum Preeclampsia; Patient Empowerment; Patient Education; Postpartum Care Interventions: Other: Video Education Sponsors: Weill Medical College of Cornell University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Metacognitive Training-Silver BeWell in Older Adults
Conditions: Depressive Symptoms; Well-Being, Psychological Interventions: Behavioral: Metacognitive Training-Silver BeWell Sponsors: Universit ätsklinikum Hamburg-Eppendorf Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Cybin Receives FDA Breakthrough Therapy Designation for its Novel Psychedelic Molecule CYB003 and Announces Positive Four-Month Durability Data in Major Depressive Disorder
TORONTO--(BUSINESS WIRE) March 13, 2024 --Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the“Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - March 13, 2024 Category: Pharmaceuticals Source Type: clinical trials
A Phase 3 Study of Psilocybin for Major Depressive Disorder (MDD)
Conditions: Depressive Disorder, Major Interventions: Drug: Psilocybin 25 mg; Drug: Inactive Placebo; Drug: Psilocybin 5 mg; Behavioral: Psychosocial Support Sponsors: Usona Institute; Worldwide Clinical Trials Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
A Clinical Study to Evaluate of Single and Multiple Oral Doses of GM-1020 in Patients With MDD
Conditions: Major Depressive Disorder Interventions: Drug: GM-1020 Sponsors: Gilgamesh Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
Effects of Volatile Anaesthetics on Incidence of Postoperative Depression and Anxiety in Elderly Patients
Conditions: Cohort Studies Interventions: Drug: volatile anaesthetic (sevoflurane, isoflurane, desflurane) Sponsors: Chinese PLA General Hospital; Beijing Tsinghua Changgeng Hospital; Peking University First Hospital; The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School; Xiangya Hospital of Central South University; Beijing Anzhen Hospital; Central South University; Peking University People ' s Hospital; Zhejiang University; Fudan University; Sun Yat-sen University; Wuhan Union Hospital, China; China-Japan Friendship Hospital; The Affiliated Hospital Of Guizhou Medical University; First Affiliate...
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
Trial of Mirtazapine for Depression in IBD
Conditions: Major Depressive Disorder; Inflammatory Bowel Diseases Interventions: Drug: Mirtazapine; Drug: Placebo Sponsors: King ' s College London; King ' s College Hospital NHS Trust; Imperial College London; London North West Healthcare NHS Trust; Imperial College Healthcare NHS Trust; Guy ' s and St Thomas ' NHS Foundation Trust Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
Development of an Online ACT Intervention for Disorders of Gut-Brain Interaction
Conditions: Clinically Meaningful Symptoms Levels of Symptoms of DGBI and Depression and/or Anxiety Sponsors: Örebro University, Sweden Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
A One-year Trajectory of Depression Status Changes in Elderly Patients With MCI and SD: a Longitudinal Cohort Study
Conditions: Mild Cognitive Impairment; Subthreshold Depression; Older Adults Sponsors: Fujian Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
Psilocybin for Major Depressive Disorder (MDD)
Conditions: Depressive Disorder, Major Interventions: Drug: Psilocybin 25 mg; Drug: Inactive Placebo; Drug: Psilocybin 5 mg; Behavioral: Psychosocial Support Sponsors: Usona Institute; Worldwide Clinical Trials Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
The clinical effectiveness of a self-management intervention for patients with persistent depressive disorder and their partners/caregivers: results from a multicenter, pragmatic randomized controlled trial
ConclusionAlthough depressive symptoms did not improve relative to CAU, this only confirmed that treatment for patients with treatment-resistant PDD should move from symptom reduction to functional recovery. Also, functional recovery may be reflected in other outcomes than psychosocial burden, such as self-empowerment, in patients with treatment-resistant PDD. Future research on PPEP4All-PDD could focus on a longer-term program and/or online program that may also be offered earlier in the treatment process as an empowerment intervention. Trial registrationNetherlands Trial Register Identifier NL5818. Registered on 20 Jul...
Source: Trials - March 13, 2024 Category: Research Source Type: clinical trials
Inflammatory Control of Antidepressant Efficacy: a Pharmaco-epigenetic Approach
Conditions: Mood Disorders; Major Depressive Disorder Interventions: Other: Treatment as usual (TAU), i.e., pharmacotherapy plus clinical management Sponsors: IRCCS San Raffaele Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
Promoting Teenage Sleep for Improved Mental Health and School Performance
Conditions: Mental Health Issue; Insomnia; Depression; Anxiety; Daytime Sleepiness; Wellness, Psychological Interventions: Behavioral: Sleep on Schedule; Behavioral: Technology restriction Sponsors: Kristianstad University; Karolinska Institutet; Örebro University, Sweden; Academic Primary Health Care Centre, Region Stockholm Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
Immune Activation, Neural Plasticity and Depression
Conditions: Mood Disorders; Major Depressive Disorder; Sleep Deprivation Interventions: Other: Total sleep deprivation Sponsors: IRCCS San Raffaele Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
